Back to Resource Center

Strategic Evaluation Framework (SEF) for MPTs: Strategic Target Profile (STP) context summaries

Strategic Evaluation Framework (SEF) for MPTs: Strategic Target Profile (STP) context summaries

Building upon the IMPT’s report: “Laying the Groundwork for a Strategic Evaluation Framework (SEF) for HIV Prevention and MPT Product Development,” the IMPT initiated the next steps to create a Strategic Target Profile (STP) for the dominant MPT product strategies in development: daily oral tablets; on-demand, intermediate acting (e.g., gel, film, vaginal insert, barrier method); long-acting topical (e.g., patch, intravaginal ring [IVR]); and ultra-long-acting systemic (e.g., implant, injectable, intrauterine device [IUD]). This exercise aimed to synthesize learnings from end-user research in HIV prevention, family planning, and MPT development to inform target-setting around the ten identified STP attributes.

Click here to View Report

October 2017

Click for full info +

Strategic Evaluation Framework (SEF) for MPTs: Strategic Target Profile (STP) context summaries

Strategic Evaluation Framework (SEF) for MPTs: Strategic Target Profile (STP) context summaries
October 2017

Building upon the IMPT’s report: “Laying the Groundwork for a Strategic Evaluation Framework (SEF) for HIV Prevention and MPT Product Development,” the IMPT initiated the next steps to create a Strategic Target Profile (STP) for the dominant MPT product strategies in development: daily oral tablets; on-demand, intermediate acting (e.g., gel, film, vaginal insert, barrier method); long-acting topical (e.g., patch, intravaginal ring [IVR]); and ultra-long-acting systemic (e.g., implant, injectable, intrauterine device [IUD]). This exercise aimed to synthesize learnings from end-user research in HIV prevention, family planning, and MPT development to inform target-setting around the ten identified STP attributes.

Click here to View Report

In this Technical Brief:
Health Risk(s):

  • HIV
  • Unintended Pregnancy
    • Product Type(s):

  • ARVs
  • Cervical Barrier
  • Contraceptives
  • Implants
  • IUD
  • IVR (Intravaginal Rings)
  • MPTs
  • Vaginal Cream/Gel
  • Vaginal Film
  • Other or N/A
    • Topic(s):

  • Education
  • MPTs
  • Product Development
  • Product Introduction / Uptake
    • Region(s):

  • Global


    • Full Info:


    Resource Type:

    Technical Brief

    Citation:

    Building upon the IMPT’s report: “Laying the Groundwork for a Strategic Evaluation Framework (SEF) for HIV Prevention and MPT Product Development,” the IMPT initiated the next steps to create a Strategic Target Profile (STP) for the dominant MPT product strategies in development…

    Health Risks(s):

    • HIV
    • Unintended Pregnancy

    Product type(s):

    • AVRs
    • CervicalBarrier
    • Contraceptives
    • Implants
    • IUD
    • IVR
    • MPTs
    • VaginalCream
    • VaginalFilm
    • Other

    Topic(s):

    • Education
    • MPTs
    • Development
    • Product Introduction

      Region(s)

      • Global

      Back to Resource Center